- Home
- EDSA vs CARV Comparison
EDSA vs CARV Comparison
Compare EDSA & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- CARV
- Stock Information
- Founded
- EDSA 2015
- CARV 1948
- Country
- EDSA Canada
- CARV United States
- Employees
- EDSA N/A
- CARV N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- CARV Savings Institutions
- Sector
- EDSA Health Care
- CARV Finance
- Exchange
- EDSA Nasdaq
- CARV Nasdaq
- Market Cap
- EDSA 11.0M
- CARV 9.0M
- IPO Year
- EDSA N/A
- CARV 1994
- Fundamental
- Price
- EDSA $2.09
- CARV $1.71
- Analyst Decision
- EDSA Strong Buy
- CARV
- Analyst Count
- EDSA 1
- CARV 0
- Target Price
- EDSA $21.00
- CARV N/A
- AVG Volume (30 Days)
- EDSA 50.3K
- CARV 27.8K
- Earning Date
- EDSA 12-13-2024
- CARV 11-22-2024
- Dividend Yield
- EDSA N/A
- CARV N/A
- EPS Growth
- EDSA N/A
- CARV N/A
- EPS
- EDSA N/A
- CARV N/A
- Revenue
- EDSA N/A
- CARV $28,323,000.00
- Revenue This Year
- EDSA N/A
- CARV N/A
- Revenue Next Year
- EDSA N/A
- CARV N/A
- P/E Ratio
- EDSA N/A
- CARV N/A
- Revenue Growth
- EDSA N/A
- CARV 11.21
- 52 Week Low
- EDSA $2.09
- CARV $1.26
- 52 Week High
- EDSA $6.46
- CARV $2.39
- Technical
- Relative Strength Index (RSI)
- EDSA 19.32
- CARV 48.19
- Support Level
- EDSA $2.26
- CARV $1.63
- Resistance Level
- EDSA $2.44
- CARV $1.76
- Average True Range (ATR)
- EDSA 0.26
- CARV 0.09
- MACD
- EDSA -0.06
- CARV 0.00
- Stochastic Oscillator
- EDSA 0.00
- CARV 23.53
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.